To fill this gap in knowledge, in this study we analysed 10 primary USC cell lines for Her2/neu receptor expression and c-erbB2 gene amplification, and investigated Her2/neu ECD release in the supernatant of these biologically aggressive tumours. This evidence concerns the gene ERBB2 and neoplasm.